These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8310787)

  • 1. Pharmacokinetics of propofol and its conjugates after continuous infusion in normal and in renal failure patients: a preliminary study.
    Nathan N; Debord J; Narcisse F; Dupuis JL; Lagarde M; Benevent D; Lachatre G; Feiss P
    Acta Anaesthesiol Belg; 1993; 44(3):77-85. PubMed ID: 8310787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-stage renal failure reduces central clearance and prolongs the elimination half life of remifentanil.
    Dahaba AA; Oettl K; von Klobucar F; Reibnegger G; List WF
    Can J Anaesth; 2002 Apr; 49(4):369-74. PubMed ID: 11927475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of positive end-expiratory pressure ventilation on propofol concentrations during general anesthesia in humans.
    Takizawa E; Ito N; Ishizeki J; Goto F; Hiraoka H; Takizawa D
    Fundam Clin Pharmacol; 2006 Oct; 20(5):489-92. PubMed ID: 16968420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of alfentanil in chronic renal failure.
    Chauvin M; Lebrault C; Levron JC; Duvaldestin P
    Anesth Analg; 1987 Jan; 66(1):53-6. PubMed ID: 3099599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fentanyl pre-treatment does not affect the pharmacokinetic profile of an induction dose of propofol in adults.
    De Gasperi A; Cristalli A; Noé L; Sabbadini D; Mazza E; Prosperi M; Fantini G; Crespi AM; Rezzani S
    Eur J Anaesthesiol; 1994 Mar; 11(2):89-93. PubMed ID: 8174540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of rocuronium bromide in patients with and without renal failure.
    Cooper RA; Mirakhur RK; Wierda JM; Maddineni VR
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():43-4. PubMed ID: 8557005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
    Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
    Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of target-controlled infusion for propofol in patients with chronic renal failure undergoing living-related renal transplantation].
    Igarashi T; Nagata O; Iwakiri H; Ikeda M; Ozaki M
    Masui; 2009 Sep; 58(9):1143-8. PubMed ID: 19764438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of fleroxacin in renal impairment.
    Weidekamm E
    Am J Med; 1993 Mar; 94(3A):70S-74S. PubMed ID: 8452185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fentanyl pharmacokinetics in patients undergoing renal transplantation.
    Koehntop DE; Rodman JH
    Pharmacotherapy; 1997; 17(4):746-52. PubMed ID: 9250552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of propofol ('Diprivan') as an induction agent.
    Kay NH; Uppington J; Sear JW; Douglas EJ; Cockshott ID
    Postgrad Med J; 1985; 61 Suppl 3():55-7. PubMed ID: 3877295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of digitoxin in chronic renal failure (author's transl)].
    Peters U; Grabensee B; Hausamen TU; Fritsch WP; Grosse-Brockhoff F
    Dtsch Med Wochenschr; 1977 Jan; 102(4):109-15. PubMed ID: 832589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
    Mao ZL; Stalker D; Keirns J
    Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of a 0.1 mg/kg dose of cisatracurium besylate in children during N2O/O2/propofol anesthesia.
    Imbeault K; Withington DE; Varin F
    Anesth Analg; 2006 Mar; 102(3):738-43. PubMed ID: 16492821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of blood cell transfusion on the presence of propofol in blood components.
    Fijałkowska A; Dawidowicz AL; Nestorowicz A; Fornal E
    Med Sci Monit; 2001; 7(6):1334-8. PubMed ID: 11687753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.